よむ、つかう、まなぶ。
資料３－４ 研究報告の報告状況 (2 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_31510.html |
| 出典情報 | 薬事・食品衛生審議会 薬事分科会医薬品等安全対策部会（令和4年度第4回 3／2）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
研究報告の報告状況
（2022年8月1日～2022年11月30日）
NO
一般名
文献名
30 アロプリノール
Increased risk of cardiovascular events and death in the initial phase after discontinuation
of febuxostat or allopurinol: another story of the CARES trial. Ghang BZ, et al.
Rheumatology, Jeju National University College of Medicine and Graduate School of
Medicine, Jeju National University Hospital, Jeju, The Republic of Korea. RMD open 8巻2
号､頁､2022年
31 オランザピン
Sharon, R. et al..Incidence of hospital contacts with acute kidney injury after initiation of
second-generation antipsychotics in older adults: a Danish population-based cohort study.
高齢者における第二世代抗精神病薬開始後の急性腎不全による病院受診率：デンマーク
における人口ベースコホート研究．Europ. J. Clin. Pharmacol. 2022;78(8):1341-1349.
32 フェブキソスタット
33 ベンラファキシン塩酸塩
34 オクスカルバゼピン
35 プレガバリン
36 トラマドール塩酸塩・アセトアミノフェン配合剤
クリサンタスパーゼ
メルカプトプリン水和物
ホリナートカルシウム
38
レボホリナートカルシウム
37
39 精製ヒアルロン酸ナトリウム
40 フィブリノゲン加第１３因子（３）
41 オメプラゾール
42 デソゲストレル・エチニルエストラジオール
43 無水カフェイン
44 レノグラスチム（遺伝子組換え）
45 ベドリズマブ（遺伝子組換え）
46 ケトプロフェン
47 クロナゼパム
48 人血清アルブミン
49 トラネキサム酸
50 オメプラゾール
51 レベチラセタム
52 オメプラゾール
53 ランソプラゾール
54 レベチラセタム
55 ベタメタゾン・ｄ－クロルフェニラミンマレイン酸塩
Increased risk of cardiovascular events and death in the initial phase after discontinuation
of febuxostat or allopurinol: another story of the CARES trial. Ghang BZ, et al.
Rheumatology, Jeju National University College of Medicine and Graduate School of
Medicine, Jeju National University Hospital, Jeju, The Republic of Korea. RMD open 8巻2
号､頁､2022年
Ribeiro, O. Enantioselective Ecotoxicity of Venlafaxine in Aquatic Organisms: Daphnia
and Zebrafish. Environmental toxicology and chemistry. 2022;41(8):1851-1864
Adverse fetal and neonatal outcomes following in-utero exposure to oxcarbazepine: A
systematic review and meta-analysis.
Anthar F,et al.
British journal of clinical pharmacology. 2022 AUG;88(8):3600-3609.
Eroglu, T.E. et al. Risk of out-of-hospital cardiac arrest in patients with epilepsy and
users of antiepileptic drugs. Brit. J. Clin. Pharmacol. 2022; 88(8): 3709-3715.
Killion, J.A. et al. Prenatal acetaminophen use in women with autoimmune disorders and
adverse pregnancy and birth outcomes. Rheumatology. 2022; 61(4): 1630-1638.
Egnell, C. et al. Obesity as a predictor of treatment-related toxicity in children with acute
lymphoblastic leukaemia. Brit. J. Haematol. 2022; 196(5): 1239-1247.
De Francia, S. et al. Colorectal cancer chemotherapy: can sex-specific disparities impact
on drug toxicities?. Europ. J. Clin. Pharmacol. 2022; 78(6): 1029-1038.
Tiago V Pereira, et al. Viscosupplementation for knee osteoarthritis: systematic review
and meta-analysis. BMJ. 2022; 378; e069722
Janas-Naze, A. et al.Perioperative anaphylaxis to fibrin sealants in children with Noonan
Syndrome: A retrospective study.Annals of Allergy , Asthma , & Immunology.
2022;129(1):95-100.
Stefano Ciardullo,Federico Rea,Laura Savare,Gabriella Morabito,Gianluca Perseghin,
Giovanni Corrao.Prolonged use of proton pump inhibitors and risk of type 2 diabetes:
results from a large population-based nested case-control study.J. Clin. Endocrinol.
Metab. 107(7),e2671-e2679,2022 ;:.
Arshad H Mir, Vinod K Dumka, Faheem Sultan, Milindmitra K Lonare. Genotoxic effects
of drospirenone and ethinylestradiol in human breast cells (in vitro) and bone marrow cells
of female mice (in vivo). Drug and Chemical Toxicology. 2022;45(4):1493-1499
Kumar M, Ali A, Khan M, Sohail S, Saleem S, Khan M, Naz F, Khan W, Salat M, Hussain
K, Ambreen G. Relationship of caffeine regimen with osteopenia of prematurity in preterm
neonates: a cohort retrospective study. BMC pediatrics. 2022 JUL 21;22(1):437.
Wang Y, Fang C, Chen R, Yuan S, Chen L, Qiu X, et al.. rhG-CSF is associated with an
increased risk of metastasis in NSCLC patients following postoperative chemotherapy.
BMC Cancer. 2022;22:741
Agrawal M, et al. The Impact of Vedolizumab on COVID-19 Outcomes among Adult IBD
Patients in the SECURE-IBD Registry. Journal of Crohn's and Colitis. 2021;15(11):18771884
Machon, Natalia; Lewandowska, Julia; Zdanowska, Natalia; Placek, Waldemar;
Owczarczyk-Saczonek, Agnieszka. Cutaneous Adverse Drug Reactions (CADRs) Statistical Analysis of the Causal Relationship between the Drug, Comorbidities,
Cofactors, and the Cutaneous Reaction - A Single-Centered Study. International Journal
of Environmental Research and Public Health. 2022; 19(13).
Eroglu, T.E. et al. .Risk of out-of-hospital cardiac arrest in patients with epilepsy and
users of antiepileptic drugs.Brit. J. Clin. Pharmacol. 2022;88(8):3709-3715.
Li et al.. Impact of albumin infusion on progression of intensive care uit patients with
congestive heart failure-hypoalbuminemia overlap: a retrospective cohort study. Journal of
Thoracic Disease. 2022;14(6):2235-2246
Philip C. Spinella et al..
The risk of hromboembolic events with early intravenous 2-and 4-g bolus dosing of
tranexamic acid compared to placebo in patients with severe traumatic bleeding: A
secondary analysis of a randomized, double-blind,
placebo-controlled,single center trial
Trauma and Transfusion Medicine Research Center, Department of Surgery, University of
Pittsburgh, Pittsburgh, PA, USA. Transfusion 2022 62 Suppl 1 S139-S150
Petra Czarniak.Proton pump inhibitors are associated with incident type 2 diabetes
mellitus in a prospective population-based cohort study.British Journal of Clinical
Pharmacology 2022;88(6):2718-2726.
Bjork MH, et al.. Association of Prenatal Exposure to Antiseizure Medication With Risk of
Autism and Intellectual Disability. JAMA Neurol. 2022; 79(7): 672-681.
Jeong Yee.Proton pump inhibitor use and hearing loss in patients with type 2 diabetes:
Evidence from a hospital-based case-control study and a population-based cohort
study.British Journal of Clinical Pharmacology 2022;88(6):2738-3746.
Ciardullo, S. et al. (Policlinico di Monza, Monza, Italy). Prolonged use of proton pump
inhibitors and risk of type 2 diabetes: results from a large population-based nested casecontrol study. J. Clin. Endocrinol. Metab.. 2022; 107(7): e2671-e2679-.
Gozukizil, S.T. et al. (University of Health Sciences Umraniye Training and Research
Hospital, Istanbul, Turkey). Relationship between bone density and levetiracetam
monotherapy in epilepsy patients. Clin. Neurol. Neurosurg.. 2022; 218: 107270.
Ninan, K. et al. (McMaster University, Ontario, Canada). Evaluation of long-term
outcomes associated with preterm exposure to antenatal corticosteroids: A systematic
review and meta-analysis. JAMA Pediatr. 2022; 176(6): e220483-.
2
（2022年8月1日～2022年11月30日）
NO
一般名
文献名
30 アロプリノール
Increased risk of cardiovascular events and death in the initial phase after discontinuation
of febuxostat or allopurinol: another story of the CARES trial. Ghang BZ, et al.
Rheumatology, Jeju National University College of Medicine and Graduate School of
Medicine, Jeju National University Hospital, Jeju, The Republic of Korea. RMD open 8巻2
号､頁､2022年
31 オランザピン
Sharon, R. et al..Incidence of hospital contacts with acute kidney injury after initiation of
second-generation antipsychotics in older adults: a Danish population-based cohort study.
高齢者における第二世代抗精神病薬開始後の急性腎不全による病院受診率：デンマーク
における人口ベースコホート研究．Europ. J. Clin. Pharmacol. 2022;78(8):1341-1349.
32 フェブキソスタット
33 ベンラファキシン塩酸塩
34 オクスカルバゼピン
35 プレガバリン
36 トラマドール塩酸塩・アセトアミノフェン配合剤
クリサンタスパーゼ
メルカプトプリン水和物
ホリナートカルシウム
38
レボホリナートカルシウム
37
39 精製ヒアルロン酸ナトリウム
40 フィブリノゲン加第１３因子（３）
41 オメプラゾール
42 デソゲストレル・エチニルエストラジオール
43 無水カフェイン
44 レノグラスチム（遺伝子組換え）
45 ベドリズマブ（遺伝子組換え）
46 ケトプロフェン
47 クロナゼパム
48 人血清アルブミン
49 トラネキサム酸
50 オメプラゾール
51 レベチラセタム
52 オメプラゾール
53 ランソプラゾール
54 レベチラセタム
55 ベタメタゾン・ｄ－クロルフェニラミンマレイン酸塩
Increased risk of cardiovascular events and death in the initial phase after discontinuation
of febuxostat or allopurinol: another story of the CARES trial. Ghang BZ, et al.
Rheumatology, Jeju National University College of Medicine and Graduate School of
Medicine, Jeju National University Hospital, Jeju, The Republic of Korea. RMD open 8巻2
号､頁､2022年
Ribeiro, O. Enantioselective Ecotoxicity of Venlafaxine in Aquatic Organisms: Daphnia
and Zebrafish. Environmental toxicology and chemistry. 2022;41(8):1851-1864
Adverse fetal and neonatal outcomes following in-utero exposure to oxcarbazepine: A
systematic review and meta-analysis.
Anthar F,et al.
British journal of clinical pharmacology. 2022 AUG;88(8):3600-3609.
Eroglu, T.E. et al. Risk of out-of-hospital cardiac arrest in patients with epilepsy and
users of antiepileptic drugs. Brit. J. Clin. Pharmacol. 2022; 88(8): 3709-3715.
Killion, J.A. et al. Prenatal acetaminophen use in women with autoimmune disorders and
adverse pregnancy and birth outcomes. Rheumatology. 2022; 61(4): 1630-1638.
Egnell, C. et al. Obesity as a predictor of treatment-related toxicity in children with acute
lymphoblastic leukaemia. Brit. J. Haematol. 2022; 196(5): 1239-1247.
De Francia, S. et al. Colorectal cancer chemotherapy: can sex-specific disparities impact
on drug toxicities?. Europ. J. Clin. Pharmacol. 2022; 78(6): 1029-1038.
Tiago V Pereira, et al. Viscosupplementation for knee osteoarthritis: systematic review
and meta-analysis. BMJ. 2022; 378; e069722
Janas-Naze, A. et al.Perioperative anaphylaxis to fibrin sealants in children with Noonan
Syndrome: A retrospective study.Annals of Allergy , Asthma , & Immunology.
2022;129(1):95-100.
Stefano Ciardullo,Federico Rea,Laura Savare,Gabriella Morabito,Gianluca Perseghin,
Giovanni Corrao.Prolonged use of proton pump inhibitors and risk of type 2 diabetes:
results from a large population-based nested case-control study.J. Clin. Endocrinol.
Metab. 107(7),e2671-e2679,2022 ;:.
Arshad H Mir, Vinod K Dumka, Faheem Sultan, Milindmitra K Lonare. Genotoxic effects
of drospirenone and ethinylestradiol in human breast cells (in vitro) and bone marrow cells
of female mice (in vivo). Drug and Chemical Toxicology. 2022;45(4):1493-1499
Kumar M, Ali A, Khan M, Sohail S, Saleem S, Khan M, Naz F, Khan W, Salat M, Hussain
K, Ambreen G. Relationship of caffeine regimen with osteopenia of prematurity in preterm
neonates: a cohort retrospective study. BMC pediatrics. 2022 JUL 21;22(1):437.
Wang Y, Fang C, Chen R, Yuan S, Chen L, Qiu X, et al.. rhG-CSF is associated with an
increased risk of metastasis in NSCLC patients following postoperative chemotherapy.
BMC Cancer. 2022;22:741
Agrawal M, et al. The Impact of Vedolizumab on COVID-19 Outcomes among Adult IBD
Patients in the SECURE-IBD Registry. Journal of Crohn's and Colitis. 2021;15(11):18771884
Machon, Natalia; Lewandowska, Julia; Zdanowska, Natalia; Placek, Waldemar;
Owczarczyk-Saczonek, Agnieszka. Cutaneous Adverse Drug Reactions (CADRs) Statistical Analysis of the Causal Relationship between the Drug, Comorbidities,
Cofactors, and the Cutaneous Reaction - A Single-Centered Study. International Journal
of Environmental Research and Public Health. 2022; 19(13).
Eroglu, T.E. et al. .Risk of out-of-hospital cardiac arrest in patients with epilepsy and
users of antiepileptic drugs.Brit. J. Clin. Pharmacol. 2022;88(8):3709-3715.
Li et al.. Impact of albumin infusion on progression of intensive care uit patients with
congestive heart failure-hypoalbuminemia overlap: a retrospective cohort study. Journal of
Thoracic Disease. 2022;14(6):2235-2246
Philip C. Spinella et al..
The risk of hromboembolic events with early intravenous 2-and 4-g bolus dosing of
tranexamic acid compared to placebo in patients with severe traumatic bleeding: A
secondary analysis of a randomized, double-blind,
placebo-controlled,single center trial
Trauma and Transfusion Medicine Research Center, Department of Surgery, University of
Pittsburgh, Pittsburgh, PA, USA. Transfusion 2022 62 Suppl 1 S139-S150
Petra Czarniak.Proton pump inhibitors are associated with incident type 2 diabetes
mellitus in a prospective population-based cohort study.British Journal of Clinical
Pharmacology 2022;88(6):2718-2726.
Bjork MH, et al.. Association of Prenatal Exposure to Antiseizure Medication With Risk of
Autism and Intellectual Disability. JAMA Neurol. 2022; 79(7): 672-681.
Jeong Yee.Proton pump inhibitor use and hearing loss in patients with type 2 diabetes:
Evidence from a hospital-based case-control study and a population-based cohort
study.British Journal of Clinical Pharmacology 2022;88(6):2738-3746.
Ciardullo, S. et al. (Policlinico di Monza, Monza, Italy). Prolonged use of proton pump
inhibitors and risk of type 2 diabetes: results from a large population-based nested casecontrol study. J. Clin. Endocrinol. Metab.. 2022; 107(7): e2671-e2679-.
Gozukizil, S.T. et al. (University of Health Sciences Umraniye Training and Research
Hospital, Istanbul, Turkey). Relationship between bone density and levetiracetam
monotherapy in epilepsy patients. Clin. Neurol. Neurosurg.. 2022; 218: 107270.
Ninan, K. et al. (McMaster University, Ontario, Canada). Evaluation of long-term
outcomes associated with preterm exposure to antenatal corticosteroids: A systematic
review and meta-analysis. JAMA Pediatr. 2022; 176(6): e220483-.
2